New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

The UCLA trial is currently enrolling patients.

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Many patients with high-risk biochemically recurrent prostate cancer based on PSA doubling time are unidentified in clinical practice. Clinicians unaware of patients’ PSA doubling time (PSADT) at ...

Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...

While prostate cancer recurrence is a major cause of death in patients receiving localized treatment, there are other significant causes of mortality. While prostate cancer progression or recurrence ...

Former president Joe Biden was diagnosed with an aggressive form of prostate cancer, his spokesperson announced on Sunday. Biden, 82, is currently reviewing his treatment options with his family and ...